Author

Matthew Q. Schmidt

Observed name: Matthew Q Schmidt

Institution: University of Colorado Anschutz

Observed institutions: Creighton University, Cedars-Sinai Medical Center, St. Joseph's Hospital and Medical Center, Exempla Saint Joseph Hospital, Premier Dental Products (United States), University of Colorado Anschutz

ORCID: 0000-0003-0453-0271

Observed ORCID: 0000-0003-0453-0271

OpenAlex ID: A5039849055

Predictors of survival in head and neck mucosal melanoma

2017 · Matthew Q. Schmidt, John David, et al. · Oral Oncology · 43

Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer

2018 · Carlos E. Vargas, Matthew Q. Schmidt, et al. · Advances in Radiation Oncology · 17

Evaluating Novel PET-CT Functional Parameters TLG and TMTV in Differentiating Low-grade Versus Grade 3A Follicular Lymphoma

2019 · Ajay Major, Andrew Hammes, et al. · Clinical Lymphoma Myeloma & Leukemia · 12

Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor

2019 · Matthew Q Schmidt, Zachary Trenbeath, et al. · World Journal of Nuclear Medicine · 5

Absent Cerebellar Circulation With Intact Cerebral Blood Flow on a 99mTc Bicisate “Brain Death” Study

2017 · Matthew Q. Schmidt, Frank V. Schraml · Clinical Nuclear Medicine · 3

18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of a rare mycotic aneurysm of the thoracic aorta in a patient with fever of unknown origin

2021 · Matthew Q. Schmidt, Rola Altoos, et al. · World Journal of Nuclear Medicine · 1

Cervical left pulmonary artery

2018 · Matthew Q Schmidt, Michael Hafertepe, et al. · Journal of Surgical Case Reports

Toxicity, quality of life outcomes, and dosimetric impact in phase III trial of hypofractionated or standard fractionated proton therapy for low-risk prostate cancer patients: PCG GU 002.

2017 · Matthew Q. Schmidt, Carlos E. Vargas, et al. · Journal of Clinical Oncology

Sa1524 Adjuvant Versus Neo-adjuvant Radiotherapy (RT) in Pancreatic Cancer: Results from a Population Based Cancer Registry

2016 · Manraj S. Khosla, Matthew Q. Schmidt, et al. · Gastroenterology

The Effect of Counterion, Concentration, and Temperature on the Release of Bioavailable Calcium and Phosphate Ions from Ion Permeable Microcapsules for Remineralization

2013 · Michelle A. Falbo, Matthew Q. Schmidt, et al. · ACS symposium series

Works count: 10

Citation count: 81

H-index: 4

I10-index: 3